Qube Research & Technologies (QRT)’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-418,940
Closed -$12.5M 4060
2025
Q3
$12.5M Buy
418,940
+24,956
+6% +$833K 0.01% 1179
2025
Q2
$11.7M Buy
393,984
+4,799
+1% +$138K 0.01% 1200
2025
Q1
$11.9M Sell
389,185
-64,836
-14% -$2.18M 0.01% 1018
2024
Q4
$18M Buy
454,021
+50,348
+12% +$1.96M 0.02% 768
2024
Q3
$15.7M Buy
403,673
+301,675
+296% +$12.2M 0.02% 790
2024
Q2
$4.29M Buy
101,998
+92,073
+928% +$3.14M 0.01% 1329
2024
Q1
$291K Buy
9,925
+847
+9% +$27K ﹤0.01% 2833
2023
Q4
$330K Buy
9,078
+3,018
+50% +$98.9K ﹤0.01% 2533
2023
Q3
$194K Sell
6,060
-952
-14% -$32.3K ﹤0.01% 2417
2023
Q2
$220K Sell
7,012
-27,559
-80% -$629K ﹤0.01% 1750
2023
Q1
$788K Buy
+34,571
New +$890K ﹤0.01% 1384

Other funds holding SRDX

Qube Research & Technologies (QRT)'s SRDX Position: Q4 2025 in Review

Qube Research & Technologies (QRT) sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 418,940 shares — an estimated $12.5M sold.

Qube Research & Technologies (QRT) first reported a position in SRDX in Q1 2023 and held it in 11 quarters. The position peaked at $18M in Q4 2024. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • Qube Research & Technologies (QRT) reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 418,940 Surmodics shares in Q4 2025, an estimated $12.5M.
  • Qube Research & Technologies (QRT) first reported a position in Surmodics in Q1 2023 and held it in 11 quarters.
  • Qube Research & Technologies (QRT)'s Surmodics position peaked at $18M in Q4 2024.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2025, filed 17 Feb 2026.